Comparison of antibacterial effects between antimicrobial peptide and bacteriocins isolated from Lactobacillus plantarum on three common pathogenic bacteria

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 5806-5811

  Ming, Liu ^a   Zhang, Qian ^a   Yang, Le ^a   Huang, Jian An ^b  

^a THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Antimicrobial activity; Antimicrobial peptide; Bacteriocin; Biofilm

Indexed keywords

BACTERIOCIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; DISK DIFFUSION; FLUORESCENCE MICROSCOPY; LACTOBACILLUS PLANTARUM; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS SANGUINIS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS PLANTARUM; STAPHYLOCOCCUS AUREUS;

EID: 84931287886     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sang Y and Blecha F. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. An Health Res Rev 2008; 9: 227-235.
2. Timurkaynak F, Can F, Azap ÖK, Demirbilek M, Arslan H and Karaman SÖ. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agent 2006; 27: 224-228.
3. Wright GD. Antibiotics: a new hope. Chem Biol 2012; 19: 3-10.
4. Piddock LJ. The crisis of no new antibiotics-what is the way forward? Lancet Infect Dis 2012; 12: 249-253.
5. Spellberg B, Bartlett JG and Gilbert DN. The future of antibiotics and resistance. Zasloff Michael 2013; 368: 299-302.
6. Todorov SD, Rachman C, Fourrier A, Dicks LM, Van Reenen CA, Prévost H and Dousset X. Characterization of a bacteriocin produced by Lactobacillus sakei R1333 isolated from smoked salmon. Anaerobe 2011; 17: 23-31.
7. Messaoudi S, Manai M, Kergourlay G, Prévost H, Connil N, Chobert JM and Dousset X. Lactobacillus salivarius: Bacteriocin and probiotic activity. Food Microbiol 2013; 36: 296-304.
8. Corr SC, Li Y, Riedel CU, O’Toole PW, Hill C and Gahan CG. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Pro Nat Acad Sci 2007; 104: 7617-7621.
9. Garneau S, Martin NI and Vederas JC. Two-peptide bacteriocins produced by lactic acid bacteria. Biochimie 2002; 84: 577-592.
10. Todorov S and Dicks L. Lactobacillus plantarum isolated from molasses produces bacteriocins active against Gram-negative bacteria. Enzyme Microb Technol 2005; 36: 318-326.
11. Svetoch EA, Eruslanov BV, Levchuk VP, Perelygin VV, Mitsevich EV, Mitsevich IP, Stepanshin J, Dyatlov I, Seal BS and Stern NJ. Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin and spectra of antimicrobial activity. Appl Environ Microbiol 2011; 77: 2749-54.
12. Lash BW, Mysliwiec TH and Gourama H. Detection and partial characterization of a broad-range bacteriocin produced by Lac-tobacillus plantarum(ATCC 8014). Food Mi-crobiol 2005; 22: 199-204.
13. Christopher AB, Arndt A, Cugini C and Davey ME. A streptococcal effector protein that inhibits Porphyromonas gingivalis biofilm development. Microbiol (Reading Engl) 2010; 156: 3469-3477.
14. Gardiner G, O’sullivan E, Kelly J, Auty M, Fitzgerald G, Collins J, Ross R and Stanton C. Comparative survival rates of human-derived probioticlactobacillus paracasei and l. salivariusstrains during heat treatment and spray drying. Appl Environ Microbiol 2000; 66: 2605-2612.
15. Lewus CB, Kaiser A and Montville TJ. Inhibition of food-borne bacterial pathogens by bacteriocins from lactic acid bacteria isolated from meat. Appl Environ Microbiol 1991; 57: 1683-1688.
16. You J, Xue X, Cao L, Lu X, Wang J, Zhang L and Zhou S. Inhibition of Vibrio biofilm formation by a marine actinomycete strain A66. Appl Microbiol Biotechnol 2007; 76: 1137-1144.
17. Lin X, Chen X, Chen Y, Jiang W and Chen H. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral Dis 2015; 21: e128-34.
18. Zacheus OM, Iivanainen EK, Nissinen TK, Lehtola MJ and Martikainen PJ. Bacterial biofilm formation on polyvinyl chloride, polyethylene and stainless steel exposed to ozonated water. Water Res 2000; 34: 63-70.
19. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton J and Greenberg E. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998; 280: 295-298.
20. Severina E, Severin A and Tomasz A. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. J Anti Chemothe 1998; 41: 341-347.
21. Hassan M, Kjos M, Nes I, Diep D and Lotfipour F. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol 2012; 113: 723-736.
22. Wimley WC and Hristova K. Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol 2011; 239: 27-34.
23. Mishra NN, McKinnell J, Yeaman MR, Rubio A, Nast CC, Chen L, Kreiswirth BN and Bayer AS. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 2011; 55: 4012-4018.
24. Jiang Z, Vasil AI, Gera L, Vasil ML and Hodges RS. Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, ‘specificity determinants,’ total hydrophobicity, hydropho-be type and location as design parameters to improve the therapeutic ratio. Chem Biol Drug Des 2011; 77: 225-240.
25. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K and Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443-451.
26. Chateau N, Castellanos I and Deschamps A. Distribution of pathogen inhibition in the Lactobacillus isolates of a commercial probiotic consortium. J Appl Bacteriol 1993; 74: 36-40.
27. Simova E, Beshkova D and Dimitrov ZP. Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products. J Appl Microbiol 2009; 106: 692-701.
28. Le Loir Y, Baron F and Gautier M. Staphy-lococcus aureus and food poisoning. Genet Mol Res 2003; 2: 63-76.
29. Tosh PK, Disbot M, Duffy JM, Boom ML, Heseltine G, Srinivasan A, Gould CV and Berríos-Torres SI. Outbreak of Pseudomonas aeruginosa surgical site infections after arthroscopic procedures: Texas, 2009. Infect Control Hosp Epidemiol 2011; 32: 1179-1186.
30. Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R and Oliver A. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J Antimicro Chemothe 2011; 66: 2022-2027.
31. Lowrance J, Baddour L and Simpson W. The role of fibronectin binding in the rat model of experimental endocarditis caused by Streptococcus sanguis. J Clin Invest 1990; 86: 7.
32. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity*. Annu Rev Med 2013; 64: 175-188.